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Pax6 is required intrinsically by thalamic
progenitors for the normal molecular
patterning of thalamic neurons but not the
growth and guidance of their axons
James M. Clegg1, Ziwen Li1, Michael Molinek1, Isabel Martín Caballero1,2, Martine N. Manuel1 and David J. Price1*
Abstract
Background: In mouse embryos, the Pax6 transcription factor is expressed in the progenitors of thalamic neurons
but not in thalamic neurons themselves. Its null-mutation causes early mis-patterning of thalamic progenitors. It is
known that thalamic neurons generated by Pax6−/− progenitors do not develop their normal connections with the
cortex, but it is not clear why. We investigated the extent to which defects intrinsic to the thalamus are responsible.
Results: We first confirmed that, in constitutive Pax6−/− mutants, the axons of thalamic neurons fail to enter the
telencephalon and, instead, many of them take an abnormal path to the hypothalamus, whose expression of Slits
would normally repel them. We found that thalamic neurons show reduced expression of the Slit receptor Robo2 in
Pax6−/− mutants, which might enhance the ability of their axons to enter the hypothalamus. Remarkably, however,
in chimeras comprising a mixture of Pax6−/− and Pax6+/+ cells, Pax6−/− thalamic neurons are able to generate axons
that exit the diencephalon, take normal trajectories through the telencephalon and avoid the hypothalamus. This
occurs despite abnormalities in their molecular patterning (they express Nkx2.2, unlike normal thalamic neurons)
and their reduced expression of Robo2. In conditional mutants, acute deletion of Pax6 from the forebrain at the
time when thalamic axons are starting to grow does not prevent the development of the thalamocortical tract,
suggesting that earlier extra-thalamic patterning and /or morphological defects are the main cause of
thalamocortical tract failure in Pax6−/− constitutive mutants.
Conclusions: Our results indicate that Pax6 is required by thalamic progenitors for the normal molecular patterning
of the thalamic neurons that they generate but thalamic neurons do not need normal Pax6-dependent patterning
to become competent to grow axons that can be guided appropriately.
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Background
The highly conserved transcription factor Pax6 is re-
quired for normal thalamic development [1–10]. It is
expressed in thalamic progenitor cells at the earliest
stages of diencephalic development, is later progressively
downregulated in these progenitors and is not expressed
in postmitotic thalamic neurons [3, 11–14]. One of its
early functions is to ensure the normal molecular
patterning of thalamic progenitors by repressing the ex-
pression of Shh [10]. In its absence, thalamic neurons are
produced, albeit in reduced numbers, and they retain an
expression profile similar in many respects to that of nor-
mal thalamic neurons [2–7]. Pax6 is, however, required
for the development of thalamocortical axons (TCAs),
which connect the thalamus to the cortex [6, 7, 15–17].
The reasons for this are poorly understood and might lie
inside or outside the thalamus. Pax6 is expressed not only
in the thalamus but also by cells in extra-thalamic di-
encephalic and ventral telencephalic regions through
which TCAs normally grow and in the cerebral cortex
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itself; this extra-thalamic expression is contemporaneous
with TCA formation [6, 13, 18]. Pinon et al. [19] used con-
ditional mutants to generate a cortex-specific deletion of
Pax6 and found that Pax6 is not required by cortical cells
for TCA development. Previous studies have not tested
whether Pax6 is required cell autonomously by thalamic
neurons for the development of their axons. We set out to
compare axonal development in Pax6−/− thalamic neurons
in constitutive Pax6−/− mutants and in Pax6−/−↔Pax6+/+
chimeras to discover whether the axons of mutant thal-
amic neurons have the competence to grow appropriately.
In mouse embryos, TCAs begin to grow at about em-
bryonic day 12.5 (E12.5). They extend rostro-ventrally
through the adjacent prethalamus before turning lat-
erally, away from the hypothalamus, to enter the ventral
telencephalon by E13.5. After crossing the ventral telen-
cephalon, they turn dorsally into the developing cortex.
They reach the correct regions of the cortex by about
E18.5 [16, 20–22]. The mechanisms that guide these
axons are likely to include both positive and negative
cues, guiding the axons towards correct targets or away
from incorrect targets respectively. There is evidence
that the positive cues include early pioneer axons origin-
ating in the ventral telencephalon that grow to the thal-
amus and provide guidance for thalamic axons on the
first part of their journey towards the cortex [23–26].
Data on the timing of the development of these ventral
telencephalic projections combined with evidence that
mutant mice showing absence, shrinkage or displace-
ment of this population also show defective TCA exten-
sion into the ventral telencephalon are consistent with
the idea that ventral telencephalic projections might act
as a scaffold [27]. Previous studies have shown defects of
these projections in Pax6−/− embryos that might go at
least some way towards explaining the TCA defects in
these mutants [21, 28, 29].
Regarding the molecular cues that guide TCA develop-
ment, the guidance receptors Robo 1 and 2 and their li-
gands Slit 1 and 2 [30] have been shown to play
important roles [31–36]. There is evidence that negative
cues operate as thalamic axons exit the prethalamus, at
which point they turn sharply laterally away from the
hypothalamus in the direction of the diencephalic-
telencephalic border. Several studies have shown that: (i)
hypothalamic explants repel thalamic axons in explant
cultures [7, 35]; (ii) the hypothalamus expresses high
levels of Slits, which are generally chemorepellent for
growing axons, and thalamic axons express the Robo re-
ceptors through which they signal; (iii) in both Slit2−/−
and Slit1−/−;Slit2−/− mutants, a large number of thalamic
projections fail to enter the telencephalon and instead
descend into the hypothalamus [26, 31, 34, 35]. These
findings provide compelling evidence that Slit-mediated
repulsion contributes to the deflection of thalamic
axons away from the hypothalamus and across the
diencephalic-telencephalic boundary.
Here, we found that thalamic neurons show reduced
expression of the Slit receptor Robo2 in Pax6−/− mutants,
which might enhance the ability of their axons to enter
the hypothalamus. In chimeras comprising a mixture of
Pax6−/− and Pax6+/+ cells, Pax6−/− thalamic neurons were
able to generate axons that exit the diencephalon, take
normal trajectories through the telencephalon and avoid
the hypothalamus, despite abnormalities in their molecu-
lar patterning. Our findings indicate that Pax6 is required
by thalamic progenitors for the normal molecular pattern-
ing of the thalamic neurons that they generate but thal-
amic neurons do not need normal Pax6-dependent
patterning to become competent to grow axons that can
be guided appropriately.
Results
Severe thalamic axonal pathfinding defects in
Pax6−/− mice
In the normal mouse diencephalon at E12.5, when TCAs
are starting to grow, Pax6 is expressed by progenitor
cells in the thalamus and by both progenitors and post-
mitotic neurons in the prethalamus (Fig. 1a). Pax6 is not
expressed by postmitotic neurons in the thalamus. The
thalamic postmitotic layer expands over the following
days, leaving only a few Pax6+ cells at the ventricular
edge (arrow in Fig. 1b). Postmitotic Pax6+ cells persist
in the prethalamus (Fig. 1b).
We used the carbocyanine dye, DiI, to label axons
exiting the thalamus in wild-type (WT) and Pax6−/−
brains from E14.5-18.5. Whereas axons extended from
the thalamus through the ventral telencephalon and
were crossing the pallial-subpallial boundary (PSPB) in
E14.5 WT brains (Fig. 1c), no such axons were labelled
in Pax6−/− brains (Fig. 1d). In E16.5 WT brains, many
more TCAs extended across the PSPB to reach the cor-
tex (Fig. 1e), but in Pax6−/− brains only small numbers
of axons extended from the thalamus and, rather than
crossing into the ventral telencephalon, they invaded
the hypothalamus (Fig. 1f–h), a region normally repul-
sive to thalamic axons [7, 35]. Thalamic axons had
made no further progress into the ventral telenceph-
alon at E18.5 in Pax6−/− embryos (Fig. 1i, j) (note that
Pax6−/− embryos do not survive for a significant time
after birth).
L1 immunohistochemistry was used to label ascending
axons from the thalamus and descending axons from
the cortex between E14.5 and E18.5 since both TCAs
and corticofugal axons express L1 throughout this
period [15]. Fig. 2a, c, e shows L1+ axons of these tracts
in Pax6+/+ brains between E14.5 and E18.5. In Pax6−/−
brains, we observed large bundles of L1-labelled axons
within the ventral telencephalon close to the amygdaloid
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Fig. 1 TCA pathfinding defects in Pax6−/− mice. a, b Normal expression of Pax6 shown with immunohistochemistry at E12.5 and E15.5; Th,
thalamus; PTh, prethalamus; Hy, hypothalamus; vTel, ventral telencephalon. Arrow indicates residual Pax6 staining in the ventricular zone at E15.5.
c, e DiI placement in the thalamus of WT mice reveals TCAs extending through the ventral telencephalon at E14.5 and entering the cortex in
greater numbers by E16.5. d, f DiI placement in the thalamus of Pax6−/− mice shows no axons leaving the thalamus at E14.5; at E16.5 a small
number of thalamic axons can be seen heading towards the hypothalamus, while no axons are observed in the ventral telencephalon (f). g, h
Boxed areas in e,f at higher magnification. i, j DiI placement in the thalamus of Pax6−/− mice shows the failure of axons to leave the
diencephalon at E18.5; boxed area in I is shown in j. k, m DiI placement close to the amygdaloid region in Pax6+/+ mice does not label any
major axon tract whereas (l, n) in Pax6−/− mice it labels a large axon tract within the ventral telencephalon and a large number of cell bodies
close to the PSPB (n). Inset in l shows the lack of DiI labelling within the thalamus, demonstrating that the labelled axons are not of thalamic
origin. Boxed areas in k,l are shown at higher magnification in m,n; broken line in M = PSPB. o, q DiI placement close to the PSPB in Pax6+/+
mice labels the thalamocortical tract (o), cell bodies within the thalamus (q) and axons descending to sub-striatal targets (arrow in o). p, r In
Pax6−/− mice it reveals a large bundle of axons that extend ventrally (p) and are tipped with growth cones (r). Boxed areas in (o, p) are shown
at higher magnification in (q, r). s, t DiI placement close to the amygdaloid region in Pax6+/+ mice gave similar results at E18.5 to those at E16.5.
u, v Schematic diagrams summarising the axon pathfinding defects observed in Pax6−/− mice (v) compared to Pax6+/+ mice (u). DiI injections
sites with relevant panels are marked. Scale bars: a–f, i, k, l, o, p, s 500 μm, g, h, j, m, n, q, r 100 μm, t 10 μm
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region at E14.5 and extending between this region and
the PSPB by E16.5 and E18.5 (Fig. 2b, d, f ). We investi-
gated these axons further with DiI labelling to discover
their origin.
DiI was placed at each end of the Pax6−/− ventral tel-
encephalic L1+ tract, either (i) in the amygdaloid region
in the ventral aspect of the ventral telencephalon, or (ii)
close to the PSPB. DiI in the amygdaloid region (ventral
to the internal capsule) did not label any long-range
axonal tract to or from this area in WT brains (Fig. 1k, m),
but in Pax6−/− brains it labelled an axon tract running be-
tween it and the PSPB (Fig. 1l, n, s, t). Numerous cell bodies
were retrogradely labelled around the PSPB (mainly ventral
to it) (Fig. 1l, n, t) but none were labelled in the thalamus
(Fig. 1l). In WT brains, DiI placement at the PSPB labelled
axons passing through or originating in this region, includ-
ing (i) thalamocortical axons and their cell bodies in the
thalamus, (ii) corticofugal axons with their cell bodies in
the cortex and (iii) striatal neurons with their cell bodies at
the injection site and axons projecting to sub-striatal targets
in the substantia nigra (Fig. 1o, q). In Pax6−/− brains, DiI at
the PSPB only labelled axons tipped with growth cones ex-
tending towards the amygdaloid region (Fig. 1p, r).
These experiments reveal an aberrant axon tract in the
Pax6−/− ventral telencephalon. It originates from cells
close to the PSPB that project axons in a ventral direc-
tion towards the amygdaloid region and is not connected
to the thalamus. It is possible that this is a misrouted
striatonigral pathway [37]. Our results indicate that
many axons leaving the thalamus grow to the hypothal-
amus but not the ventral telencephalon, as summarized
in Fig. 1(u, v).
Robo2 expression is reduced in the Pax6−/− thalamus
We considered the question of why Pax6−/− thalamic
axons failed to avoid the hypothalamus in Pax6−/− mu-
tants. Since Slit1 and Slit2 and Robo1 and Robo2 normally
provide cues that steer TCAs away from the hypothal-
amus [31, 33, 35], we examined their expression by in situ
hybridisation and quantitative reverse-transcription PCR
(qRT-PCR) in WTand Pax6−/− mice.
Slit1 and Slit2 are expressed in the hypothalamus of
WT and Pax6−/− embryos at E13.5 (Fig. 3a–h). To quan-
tify the level of Slit mRNA expression we performed
quantitative RT-PCR using tissue from the hypothal-
amus: we found no significant differences in the levels of
Slit1 or Slit2 expression between Pax6−/− and WT mice
(Fig. 3i, j). In the E13.5 WT, Robo1 is expressed in the
thalamus, close to the ventricular zone at the midline
(Fig. 3k, l). Robo2 is expressed in the body of the thal-
amus, where the differentiating neurons are located
(Fig. 3m, n). In the E13.5 Pax6−/− mouse, Robo1 is
expressed in a similar location to that in WTs (Fig. 3o,p).
Although the expression domain of Robo1 is reduced in
size, qRT-PCR using tissue from the thalamus showed
no significant difference in the levels of Robo1 expres-
sion between Pax6−/− and WT mice (Fig. 3s), indicating
that the reduction in expression domain is in proportion
to the reduction in the size of the thalamus that occurs
in these mutants. The level of Robo2 expression within
the E13.5 Pax6+/+ thalamus, however, showed a signifi-
cant overall reduction (Student’s t-test, n = 5 WT and 5
mutants, p = 0.03; Fig. 3t). The reduction appeared
greatest in rostral thalamus (Fig. 3q,r). A reduction in
Robo2 expression by Pax6−/− thalamic neurons might
contribute to their axons’ abnormal invasion of the
hypothalamus.
Fig. 2 L1 labelled forebrain axonal tracts are abnormal in Pax6−/−
embryos. Immunohistochemistry for axonal marker L1 labels axonal
tracts at E14.5 (a, b), E16.5 (c, d) and E18.5 (e, f). In Pax6+/+ embryos
TCAs and corticofugal axons can be observed running between the
thalamus and cortex (a, c, e). In Pax6−/− embryos L1 labels an axon
tract within the ventral telencephalon which increases in size
between E14.5 and E18.5 (b, d, f). g, h Boxes mark the approximate
areas shown in (a–f). Scale bar: 500 μm
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Cell autonomous defects of gene expression in Pax6−/−
thalamic neurons
The findings described above indicate major defects of
thalamic neurons in Pax6−/− embryos. We tested whether
Pax6−/− thalamic neurons show defects, first of gene ex-
pression and later of axonal growth, in Pax6−/−↔Pax6+/+
chimeras comprising a majority of Pax6+/+ cells. Pax6−/−
cells in chimeras were marked by a GFP transgene (Fig. 4).
Defects detected in mutant neurons surrounded by a ma-
jority of WT cells are more likely to be caused by mecha-
nisms intrinsic to the Pax6−/− lineage. Figure 4d–f shows
images from three different chimeras taken from the
region outlined in purple in Fig. 4c: consistently, most
neurons in the thalamus of our chimeras were WT.
Figure 4a, b shows that Robo2 is normally expressed
throughout the WT embryonic thalamus. In chimeras,
Pax6−/− thalamic neurons showed reduced Robo2 expres-
sion compared to their WT neighbours (Fig. 4g–i”; data
are from three different regions of the thalamus of the
same chimera, outlined in grey in Fig. 4c). This suggested
that their reduced expression of Robo2 is a direct conse-
quence of the absence of Pax6 from their progenitors.
We also examined the expression of markers of di-
encephalic patterning in chimeras (Fig. 5). These markers
were: (i) Nkx2.2, whose expression is normally restricted
to domains around the border between thalamus and pre-
thalamus including the ventral lateral geniculate nucleus
(vLG) but expands throughout the thalamus in Pax6−/−
embryos (Fig. 5b, c); (ii) Prox1 and Sox2, which retain
their expression in the thalamus of Pax6−/− embryos
(Fig. 5h, i, m–o) [2, 10]; (iii) Lhx1/5, whose expression is
normally restricted to the boundary of thalamus and pre-
thalamus and the vLG (Fig. 5m) and expands through the
prethalamus but not the thalamus of Pax6−/− mutants at
E16.5 (Fig. 5n, o). The most striking abnormality in chi-
meras was expression of Nkx2.2 throughout the thalamus
by Pax6−/− neurons (Fig. 5d–g). Clusters of mutant cells
in chimeras did not show any obvious signs of losing
Prox1 expression (Fig. 5j, k). As a consequence, many
Nkx2.2, Prox1 double-labelled mutant cells were identified
throughout the thalamus (Fig. 5l). Such cells would never
normally be present since the domains of Prox1 and
Nkx2.2 do not normally overlap. Pax6−/− neurons did not
upregulate Lhx1/5 in the thalamus of chimeras (Fig. 5p,
Fig. 3 Hypothalamic Slit expression is maintained while thalamic Robo2 expression is reduced in Pax6−/− embryos at E13.5. a–d In situ
hybridisation at E14.5 shows Slit1 and Slit2 mRNA expression at the hypothalamus in Pax6+/+ embryos (arrows, a,c,d). e–h In situ hybridisation
shows that Slit1 and Slit2 mRNA expression is maintained in the hypothalamus in Pax6−/− embryos (arrows e, g, h). i, j Quantitative RT-PCR on tissue
from the hypothalamus shows no significant difference in Slit1 (i) and Slit2 (j) mRNA expression between Pax6+/+ and Pax6−/− embryos (Student’s
t-tests, n = 5 WT and 5 mutants). k–n In situ hybridisation for Robo1 and Robo2 shows mRNA expression of both genes within the thalamus of Pax6+/+
embryos (arrows k,m,n). o–r In situ hybridisation in Pax6−/− embryos shows that Robo1 expression is still present within the thalamus although the
expression domain appears reduced in size (arrow o). In situ hybridisation for Robo2 shows that the expression is reduced within the thalamus of
Pax6−/− embryos, particularly at rostral levels (q). s, t Quantitative RT-PCR performed on the whole thalamus shows that while there is no difference in
Robo1 expression between Pax6+/+ and Pax6−/− embryos (s; Student’s t-test, n = 5 WT and 5 mutants), Robo2 mRNA expression is significantly reduced
in Pax6−/− embryos compared to Pax6+/+ embryos (t; Student’s t-test, n = 5 WT and 5 mutants, p = 0.03). Scale bars: 500 μm
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q). Where mutant cells were located close to the border of
thalamus and prethalamus, they expressed either Lhx1/5
or Sox2 but not both (Fig. 5r, s). Pax6−/− thalamic cells
expressed Sox2, as did their WT neighbours (Fig. 5t).
These findings suggest that Pax6−/− thalamic neurons in
chimeras are partially mis-patterned to express an abnor-
mal combination of transcription factors, some of which
they would normally express and at least one of which
they would not.
Axons of Pax6−/− thalamic neurons follow a normal
trajectory in chimeras
In Pax6−/−↔Pax6+/+ chimeras, Pax6−/− cells were la-
belled with tauGFP, allowing their axons to be visualized.
Chimeras were studied at E13.5, which is before
corticofugal axons have extended across the ventral telen-
cephalon to the thalamus, so avoiding potential confusion
between GFP+ thalamic axons and GFP+ corticofugal
axons. By E13.5, WT TCAs have turned into the ventral
telencephalon and generated the internal capsule but have
not yet reached the PSPB [21]. As for the gene expression
analysis, we examined chimeric embryos in which the ma-
jority of cells were Pax6+/+ (Fig. 6a).
We observed that tauGFP Pax6−/− axons arising from
small clusters of mutant cells in the thalamus (Fig. 6b)
were able to exit the thalamus (Fig. 6c, d) and traverse
the internal capsule with a trajectory that overlapped the
normal L1+ thalamocortical tract in chimeras (Fig. 6e).
There was no evidence of an abnormal projection of
mutant cells to the hypothalamus. This remarkable res-
cue indicates that thalamic cells do not have a cell au-
tonomous inability to generate axons that can follow a
normal route out of the diencephalon. Their intrinsic
molecular defects described above are insufficient to
prevent their axons from being guided into the telen-
cephalon by surrounding WT cells and their axons.
Pax6 loss at the time of thalamic axonal growth does not
prevent TCA formation
Since Pax6 is not required to generate thalamic neurons
with the competence to grow axons that can be guided
appropriately, the failure of TCA development in consti-
tutive Pax6−/− mutants is presumably caused by defects
extrinsic to thalamic neurons and/ or their axons. Cells
in the environment of thalamic neurons and/ or their
axons might need Pax6 at the time when TCAs are
forming to provide adequate molecular/ morphological
support. Alternatively, they might have needed Pax6 be-
fore TCAs start forming to establish the correct condi-
tions. To distinguish between these two possibilities, we
conditionally inactivated Pax6 using tamoxifen adminis-
tered at E9.5 to Pax6loxP embryos ubiquitously expressing
CreER from the CAGG-CreER allele [18, 38]. Tamoxifen-
treated experimental embryos carried two copies of the
floxed allele (CAGGCre; Pax6loxP/loxP), those carrying only
one copy were controls (TCAs are unaffected in Pax6+/−
embryos). Loss of Pax6 protein, which was complete be-
fore E12.5 (Fig. 7a, b), coincided with the onset of TCA
growth [16, 20–22]. By E12.5, the loss of Pax6 had already
caused some morphological changes characteristic of con-
stitutive Pax6−/− mutants, including expansion of the 3rd
ventricle, that were less severe than those in constitutive
Pax6−/− mutants of comparable age (Fig. 7a, b).
Deleted embryos were examined at E13.5-E16.5
(Fig. 7c–j). They did not show the severe TCA defects
found in Pax6−/− constitutive mutants. The thalamocor-
tical tract formed, although its growth was ~1–2 days
behind that in controls. These results strengthen greatly
the probability that the devastating effect of constitutive
Fig. 4 Reduced Robo2 expression by Pax6−/− thalamic neurons in
chimeras. a,b Robo2 expression in wild-type thalamus at E16.5.
c Diagram shows the positions of the thalamic areas photographed
in d–i”; Th, thalamus; PTh, prethalamus. d–f Examples of the
contributions of Pax6−/− (GFP+) cells to the thalamus of three
chimeras. g–i” Examples showing more intense staining for Robo2
mRNA (brown/purple) in WT cells than in clumps of GFP+ Pax6−/− cells
in the thalamus of a chimera aged E16.5. Scale bars: A,B, 100 μm; d–f,
75 μm; g–i”, 50 μm
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Fig. 5 Abnormal upregulation of Nkx2.2 by Pax6−/− neurons in chimeras. a Diagram showing the locations of the panels in the rest of the Figure.
b,c Nkx2.2 protein expression in (b) WT and (c) Pax6−/− embryos at E16.5. Expression is normally confined to a few cells along the border of
thalamus (Th) and prethalamus (PTh) and the vLG (b) but is expressed widely throughout the Pax6−/− thalamus (c). d–g Nkx2.2 is expressed by
Pax6−/− GFP+ cells, but not by WT cells, throughout the thalamus in E16.5 chimeras. h, i Prox1 protein expression in (h) Pax6+/+ and (i) Pax6−/−
embryos at E16.5. Prox1 is expressed in the WT thalamus and in the mutant thalamus, which is reduced in size. j, k Pax6−/− GFP+ cells in the
thalamus (e.g. arrow in j) do not show abnormal expression of Prox1. l Many of the Pax6−/− neurons that express (abnormally) Nkx2.2 in the thalamus
of chimeras co-express Prox1. m, n, o Sox2 and Lhx1/5 protein expression in (m) WT and (n) Pax6−/− embryos at E16.5. In both genotypes,
Sox2 is confined to the thalamus, which does not co-express Lhx1/5. p, q Pax6−/− GFP+ cells in the thalamus (e.g. arrow) do not show
abnormal expression of Lhx1/5, which is expressed as normal along the thalamic-prethalamic border and in the vLG. r–t Pax6−/− GFP+ cells
show normal expression of Lhx1/5 in the vLG and of Sox2 in the thalamus (r); Pax6−/− GFP+ cells close to the border express either one or
other of these markers but not both (s); Pax6−/− GFP+ thalamic cells express Sox2, as do their WT neighbours (t). Scale bars: b-k, m, n, p, q,
50 μm; L, 5 μm; O, 15 μm; R, 25 μm; S,T, 10 μm
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Pax6 loss on TCA development is a relatively indirect
consequence of patterning and/or morphological defects
that occur before TCAs start to form.
Discussion
Our key finding is that, while Pax6 is required cell au-
tonomously by thalamic progenitors for their neuronal
progeny to develop a correct molecular profile, it is not
required for thalamic neurons to develop the compe-
tence to grow axons that can be guided correctly out of
the thalamus and towards the cortex. This is in striking
contrast to the inability of thalamic axons to exit the di-
encephalon in constitutive Pax6−/− mutants, a finding in
line with several previous reports [6, 15, 17]. This result
is important because it rules out the possibility that
Pax6−/− thalamic neurons are intrinsically unable to grow
axons of sufficient length to exit the diencephalon.
This major rescue of the Pax6−/− mutant phenotype
presumably results from the restoration of elements
critical for normal TCA development by the Pax6+/+
cells in the chimeras. By allowing Pax6 expression dur-
ing early forebrain development and then removing it
ubiquitously as TCAs start to form we showed that the
Pax6-dependent elements required for TCA navigation
are in place before the tract forms. There are several
strong non-exclusive possibilities as to what the Pax6-
dependent elements might be. First, developing thalamic
axons might require Pax6-dependent signals from other
thalamic axons, for example those they fasciculate with,
to exit the diencephalon; these signals would be restored
in chimeras but would be absent in constitutive mutants.
Second, Pax6 is required for early patterning and mor-
phological development of the extra-thalamic dienceph-
alon and ventral telencephalon, regions through which
TCAs must navigate. Defects of these regions, which are
severe in Pax6−/− constitutive mutants [2–7, 10] but are
ameliorated in chimeras, might prevent TCA develop-
ment in constitutive mutants.
The first tissue that thalamic axons encounter as they
exit the thalamus is the prethalamus. Previous studies
have shown the importance of the prethalamus for TCA
development [16, 39, 40] and Pax6 is critical for its nor-
mal patterning [2, 5, 10]. Although thalamic axons are
able to cross the prethalamus in constitutive Pax6−/−
mutants, it is possible that a Pax6-dependent interaction
of prethalamic cells with thalamic axons might confer
on thalamic axons the ability to navigate into and
through the telencephalon. Constitutive Pax6−/− em-
bryos always show substantial narrowing and anatomical
distortion of the diencephalic-telencephalic junction
through which thalamic axons would normally navigate
[4, 5, 7]. These defects, which were not present in our
chimeras, provide an obvious mechanical explanation
for the extremely severe thalamic axonal defects in con-
stitutive Pax6−/− embryos. A loss of the ventral telence-
phalic pioneer axons that are hypothesized to guide
developing TCAs into the ventral telencephalon [23–26]
might also precipitate a failure of the thalamocortical
tract in Pax6−/− mutants. The effects of a transcription
factor such as Pax6 on a complex process such as the
development of TCAs, which involves multiple tissues
that express the transcription factor for many days be-
fore the axons grow, are likely to be numerous. It seems
probable, therefore, that multiple Pax6-loss-induced de-
fects conspire to prevent thalamic axons from expressing
their competence to grow correctly.
Interestingly, we found that the cell autonomous mo-
lecular defects of Pax6−/− thalamic do not prevent them
developing the competence to grow axons correctly.
Their reduced expression of Robo2 in chimeras was in-
sufficient to cause them to navigate incorrectly to the
hypothalamus. This might be because the magnitude of
the reduction was not large enough to tip the balance of
A C
B
D
E
Fig. 6 Pax6−/− thalamic axons can exit the diencephalon in
Pax6−/− ↔Pax6+/+ chimeras. GFP staining shows tauGFP Pax6−/−
axons arising from small clusters of mutant cells in the thalamus:
in (a), arrows mark the positions of regions imaged in slightly
different planes of section in panels (b) and (e) and the boxed
area is shown in panels (c) and (d). GFP+ Pax6−/− axons were
able to exit the thalamus and enter the internal capsule (IC) with
a trajectory that overlapped the normal L1+ thalamocortical tract.
DTB: diencephalic-telencephalic border. Scale bars: A, 500 μm;
B, 50 μm; C,D, 100 μm; E, 75 μm
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competing influences in favour of this outcome in chi-
meras. The fact that Pax6−/− thalamic neurons show
strong activation of Nkx2.2, in constitutive mutants and
chimeras, suggests that this particular transcription fac-
tor does not interfere with these neurons’ competence to
develop axons that grow correctly. In the spinal cord,
where Pax6 deletion also causes an expansion in the do-
main of Nkx2.2 expression, Nkx2.2 plays an important
role in determining whether neurons develop as projec-
tion neurons or interneurons and to the regulation of
programs generating specific types of motor neurons
[41, 42]. It is possible that the effects of its ectopic Pax6-
loss-induced expression in the thalamus are curtailed by
the maintenance of relative normality in the expression
of other patterning transcription factors.
Like Nkx2.2, regulation of Robo2 by Pax6 is not con-
fined to the thalamus. Previous work has indicted that it
also occurs in the cerebral cortex [43]. Indeed, this can
be observed in Pax6−/− mutants in Fig. 3(m, n, q, r):
Robo2 expression is reduced in the cerebral cortex,
which normally expresses Pax6, but not in ventral telen-
cephalic regions where Pax6 is not expressed. As in the
thalamus, Robo2 is expressed by cells in the Pax6 non-
expressing cortical mantle layer rather than in the Pax6
expressing cortical ventricular zone, indicating that
within both the cortical and thalamic lineages the au-
tonomous regulation of Robo2 by Pax6 in postmitotic
neurons does not occur by direct binding of Pax6 to
Robo2 regulatory elements. Most likely is that Pax6 initi-
ates changes in the levels of other transcription factors
in the progenitors and it is the persistence of these
changes in the postmitotic progeny that influence Robo2
expression. In the thalamus, Nkx2.2 might be one such
transcription factor. It will be interesting in the future to
gain a more comprehensive picture of the intrinsic, cell
autonomous actions of this transcription factor in this
important forebrain region.
Conclusion
Our study provides new information on the intrinsic ac-
tions of Pax6 within the thalamic lineage. Our results in-
dicate that Pax6 is required by thalamic progenitors for
the normal molecular patterning of the thalamic neu-
rons that they generate. However, thalamic neurons can
Fig. 7 Loss of Pax6 expression at E12.5 in CAGGCre; Pax6loxP/loxP embryos delays thalamic axonal growth. a, b Pax6 immunohistochemistry shows a
loss of Pax6 expression at E12.5 throughout the brain in CAGGCre; Pax6loxP/loxP embryos compared to controls. c–j DiI placement in the thalamus
(Th) labels TCAs extending through the prethalamus (PTh), avoiding the hypothalamus (Hy) and crossing the ventral telencephalon (vTel) to the
cortex (Cx) in both control and CAGGCre; Pax6loxP/loxP embryos between E13.5 and E16.5. c, d At E13.5, most axons in the control cross the
diencephalic-telencephalic boundary (DTB) and are half way through the ventral telencephalon, whereas in CAGGCre; Pax6loxP/loxP embryos,
the advancement of axons is delayed (white bar shows the distance between the tips of the TCAs and the pallial-subpallial boundary
[PSPB]). GE = ganglionic eminence. e, f A large number of axons in the control have crossed the PSPB at E14.5 but the axons in CAGGCre;
Pax6loxP/loxP embryos remain in the ventral telencephalon. g, h In control embryos at E15.5 TCAs navigate further into the cortex whereas
in CAGGCre; Pax6loxP/loxP embryos some axons just cross the PSPB. i, j By E16.5 TCAs have reached the cortex in both CAGGCre; Pax6loxP/loxP
and control embryos. Hip = hippocampus. Scale bars, 500 μm
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grow axons that can be guided appropriately without
the need for normal Pax6-dependent patterning. In
this region, normal Pax6-induced molecular pattern-
ing of neurons is not a prerequisite for their success-
ful development of axons.
Methods
Mice
All animal husbandry was conducted in accordance with
the UK Animals (Scientific Procedures) Act 1986. The
work was approved by the University of Edinburgh’s Vet-
erinary Ethical Review Committee leading to the award
of Project Licence (60/4545) by the Home Office (UK).
To create Pax6 null embryos we used the Pax6Sey allele
(designated Pax6−) [44]. To conditionally inactivate Pax6
we used the Pax6loxP allele [18]. For the staging of em-
bryos, midday on the day of vaginal plug detection was
considered as embryonic day 0.5 (E0.5). Cre expression
was induced in CAGGCre; Pax6loxP/loxP embryos with
10 mg tamoxifen (Sigma) administered by oral gavage of
pregnant females at a concentration of 50 mg/ml.
To obtain Pax6+/+↔Pax6−/− chimeric embryos, Pax6−/−
embryonic stem cells which carried one copy of the TP6.3
tau-GFP transgene [45, 46] were injected into blastocysts
from C57BL/6 × CBA crosses [10]. Blastocysts were then
transferred to the uterus of pseudo-pregnant females and
were allowed to develop. Resulting chimeric embryos ex-
press tau-GFP in all cells that originate from Pax6−/− em-
bryonic stem cells.
Immunohistochemistry
For embryos aged E12.5 to E15.5 heads were removed
and fixed in 4 % paraformaldehyde (PFA) in phosphate
buffered saline (PBS) overnight at 4 °C. For embryos
aged E16.5 to E18.5 the whole brain was removed and
then fixed as above. Heads/ brains were either embedded
in paraffin wax, or embedded in 4 % agarose, or cryopro-
tected by immersion in 30 % sucrose in PBS and embedded
in OCT. Wax sections or cryo-sections were incubated
with following primary antibodies: mouse anti-Lhx1/5,
mouse anti-Nkx2.2 and mouse anti-Pax6 (all 1/200,
DSHB), rabbit anti-GFP and anti-Prox1 (both 1/1000,
Abcam), rat anti-L1 (1/500, Millipore) and rabbit anti-
Sox2 (1/200, Ab5603 Chemicon).
In situ hybridisation
In situ hybridizations for Slit1, Slit2, Robo1 and Robo2
were performed on 100 μm agarose embedded sections
using digoxigenin labelled antisense riboprobes as previ-
ously described [47].
Axon tract tracing
Whole brains were dissected between E13.5 and E18.5
and fixed for at least 48 h with 4 % PFA in PBS at 4 °C.
After fixation brains were washed with PBS. For thal-
amic injection the brains were cut in half at the midline
in the sagittal plane and a small hole was made in the
medial aspect of the thalamus using a fine probe. Crys-
tals of DiI (Invitrogen) were inserted into the prepared
hole in the thalamus. For cortical or ventral telence-
phalic injection, holes were made in the desired region
of the telencephalon without any further dissection of
the brain and crystals of either DiI or DiA were inserted.
Brains were incubated in PBS at 37 °C. E14.5 brains were
incubated for 1 week while E16.5 and E18.5 brains were
incubated for 3–4 weeks. After diffusion the brains were
embedded in agarose and sectioned either coronally (telen-
cephalic injections) or at a 45° angle (thalamic injections)
at 100 μm. Sections were counterstained with TOPRO-3
diluted 1/1000 in PBS.
Quantitative reverse transcription-PCR (qRT-PCR)
Tissue samples from the thalamus and hypothalamus of
Pax6+/+ and Pax6−/− embryos were collected and flash
frozen on dry ice. Total RNA was extracted using an
RNAeasy Mini kit (Qiagen), cDNA was created using
Superscript reverse transcriptase (Invitrogen) and quan-
titative reverse transcription PCR (qRT-PCR) analysis
was then carried out using a Quantitect SYBR Green
PCR kit (Qiagen) with the following primer pairs: Slit1
(5′-CCTGCCAGATGATCAAGTGC-3′ and 5′-GCTGC
TTCTGGTAATAGTCC-3′), Slit2 (5′-TCACTGACCTG
CAGAACTGG-3′ and 5′-ACCATCTGGTCGAAGGTG
AC-3′), Robo1 (5′-GCCACTTCCATGCCTCTCAG-3′
and 5′-GTGCCTTGGACTGGACAGTG-3′), Robo2 (5′-
GCAGAAGTAAACCGGACGAA-3′ and 5′-CTCCAAG
ATTGCAGGCTCTC-3′). The abundance of each tran-
script (relative to GAPDH) was calculated.
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